Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I continuous infusion ch14.18/CHO in neuroblastoma
jRCT2091220181Phase 1Completed
- Sponsor
- Yoshiyuki Takahashi, MD, PhD Department of Developmental Pediatrics Nagoya University Graduate School of Medicine 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan
- Start
- Jun 2014
- Modality
- Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Dinutuximab beta in neuroblastoma, sponsored by Yoshiyuki Takahashi, MD, PhD Department of Developmental Pediatrics Nagoya University Graduate School of Medicine 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan. Primary endpoints: Safety and tolerability and Pain intensity. Started Jun 2014; status: completed.
02
Drugs
Dinutuximab beta
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on jRCT2091220181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2091220181.